Skip to content

Fecal Microbiota Transplantation as an Adjunctive Therapy for Refractory Ulcerative Colitis: A Single-Arm Clinical Study

Fecal Microbiota Transplantation as an Adjunctive Therapy for Refractory Ulcerative Colitis: A Single-Arm Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120017
Enrollment
Unknown
Registered
2026-03-08
Start date
2024-01-22
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

Fecal microbiota transplantation group:Intestinal microbiota transplantation (standardized donor) : Routine intestinal antibiotic treatment 3 days before treatment
Polyethylene glycol was routinely administered to clean the intestinal tract 24 hours before transplantation. Colonoscopy or indwelling tube transplantation is performed, with each transplantation con

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged18 to75 years old; 2. Meets the diagnostic criteria for refractory ulcerative colitis as per the "Consensus Opinion on the Diagnosis and Treatment of Inflammatory Bowel Disease (2018, Beijing)," with extensive disease involvement, recurrent episodes, or failure to achieve clinical or endoscopic remission after advanced therapy; 3. Able to independently provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Presence of advanced malignancies, severe infectious diseases, or hepatic or renal insufficiency; 2. Presence of contraindications for colonoscopy evaluation; 3. Patients or their families unable to understand the conditions and objectives of this study.

Design outcomes

Secondary

MeasureTime frame
Clinical response at week 8 ;Endoscopic remission;Histological remission;Adverse reactions: including but not limited to abdominal distension, abdominal pain, diarrhea, intestinal infection, bloodstream infection, septic shock, etc;Changes in fecal microbiota;

Primary

MeasureTime frame
Clinical remission at week 8 ;

Countries

China

Contacts

Public ContactLi Jingnan

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

pumcjnl@126.com+86 10 6915 4804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026